Merck Announces KEYTRUDA® (pembrolizumab) Significantly Improved Progression-Free Survival as First-Line Treatment for Advanced Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal Cancer

Merck to Hold First-Quarter 2020 Sales and Earnings Conference Call on April 28

Merck, Pfizer, Eli Lilly launch worker volunteer programs to aid in coronavirus fight

Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic

Cancer startup raises $125M for Keytruda combo drug trial

US Indexes Close Higher Monday

FDA Decisions on 5 Drugs Expected in 2nd Quarter

Johnson & Johnson, Merck share gains lead Dow's nearly 725-point surge

Johnson & Johnson, Merck share gains contribute to Dow's nearly 575-point surge

Dow soars 438 points on gains for Microsoft, Johnson & Johnson shares

Johnson & Johnson, Microsoft share gains lead Dow's 525-point surge

Johnson & Johnson, Intel share gains lead Dow's 425-point rally